drugset / Trial / NCT03954756
Exploratory Clinical Study of Apatinib and PD-1 in Treating Advanced Gastric Cancer
NaSingle-groupOpen-labelTreatment
Summary
The Purpose of This Study is to Evaluate the Efficacy and Safety of Apafitini Combined With PD1 in Patients With Advanced Gastric Cancer After Second-line Treatment Failure, Thus Providing More Options for Patients With Advanced Gastric Cancer.
Timeline
- Start
- 2019-06-01
- Primary completion
- 2021-06-01
- Completion
- 2021-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rivoceranib | Small molecule | 500 mg | Oral |